Pro-Dex director buys 18 shares via ESPP

Pro-Dex, Inc. director Angelita Domingo reported a small purchase of company stock through an employee plan.

Rhea-AI Filing Summary

Pro-Dex, Inc. director Angelita Domingo reported a small purchase of company stock through an employee plan. On 01/22/2026, she acquired 18 shares of common stock at a price of $34.36 per share in a transaction made under the company’s Employee Stock Purchase Plan, which is described as exempt under Rule 16b-3(c) and Rule 16b-3(d). After this transaction, she directly held 15,465 shares of Pro-Dex common stock.

Insider Trade Summary

Grant/Award: 18 shares

Grant/Award 1 txn

Insider Domingo Angelita Rebamontan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18	$34.36	$618.48

Holdings After Transaction: Common Stock — 15,465 shares (Direct)

Footnotes (1)

1. F1. These purchases were made pursuant to an Employee Stock Purchase Plan in exempt transactions pursuant to Rule 16b-3(c) and Rule 16b-3(d).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pro-Dex (PDEX) disclose in this Form 4?

Pro-Dex (PDEX) disclosed that director Angelita Domingo acquired 18 shares of common stock on 01/22/2026 at $34.36 per share.

How many Pro-Dex (PDEX) shares does Angelita Domingo own after the reported trade?

Following the reported transaction, Angelita Domingo directly owns 15,465 shares of Pro-Dex common stock.

Was the Pro-Dex (PDEX) insider transaction part of an employee plan?

Yes. The filing states that the purchases were made under an Employee Stock Purchase Plan in exempt transactions under Rule 16b-3(c) and Rule 16b-3(d).

What was the price paid per share in the Pro-Dex (PDEX) Form 4 transaction?

The reported purchase price was $34.36 per share for the 18 shares of Pro-Dex common stock.

Is the Pro-Dex (PDEX) Form 4 transaction direct or indirect ownership?

The Form 4 identifies the ownership of the reported shares as direct (D) by Angelita Domingo.

What is Angelita Domingo’s relationship to Pro-Dex (PDEX)?

Angelita Domingo is identified in the filing as a director of Pro-Dex, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Domingo Angelita Rebamontan

(Last) (First) (Middle)

2361 MCGAW AVENUE

(Street)

IRVINE CA 92614

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRO DEX INC [ PDEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/22/2026		A(1)		18	A	$34.36	15,465	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These purchases were made pursuant to an Employee Stock Purchase Plan in exempt transactions pursuant to Rule 16b-3(c) and Rule 16b-3(d).

	/s/ Alisha Charlton as attorney-in-fact for Angelita Domingo	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.